S
Stately Bio develops regenerative medicines using an advanced machine learning cell imaging platform. This patented technology measures cell identity, behavior, and maturation using live-cell, label-free imaging without compromising cell viability. The platform serves as an engine for discovering novel stem cell-derived therapies for cell therapy innovation.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Stately Bio develops regenerative medicines using an advanced machine learning cell imaging platform. Their patented technology measures cell identity, behavior, and maturation directly from live-cell, label-free imaging without compromising cell viability. This platform serves as an engine for discovering novel stem cell-derived therapies for regenerative medicine applications.